Coming up

Don't miss




On the frontline of horror: editing images from warzones

Read more


Ebola: UN sets target of 60 days to turn things around

Read more


Europe's Desperate Seas: Migrant Deaths Crossing Mediterranean Top 3,000 in 2014

Read more


'All is Well' for Lisa Simone

Read more


EU questions Apple's tax deals in Ireland

Read more


The Iraqi TV show where victims confront terrorists

Read more


Video: Syrian student risks her life to film IS group stronghold

Read more


Forgotten and fictional sports

Read more


Modi in America: India's Prime minister on triumphant US tour

Read more

US to invest $1 billion to battle virus


Latest update : 2009-07-13

US Health and Human Service Secretary Kathleen Sebelius announced the Federal government will contribute one billion dollars towards buying the ingredients for a swine flu vaccine, anticipated for the autumn, as the virus continues to gather pace.

AFP - The United States will commit one billion dollars toward the purchase of ingredients for a swine flu vaccine, Washington's top health official said Sunday as US deaths from the virus continued to mount.
"There will be another one billion dollars worth of orders placed to get the bulk ingredients for an H1N1 vaccination,"  Health and Human Services Secretary Kathleen Sebelius told CNN television Sunday, adding that the final vaccine likely will be ready by October.
"Congress has agreed with the president that this is the number one priority, keeping Americans safe and secure," she said, adding that US scientist are working "to get the shots in folks' arms."
Her remarks came as the Centers for Disease Control and Prevention confirmed 211 US deaths from the A(H1N1) virus, with some 37,000 cases confirmed -- the highest level of death and infection of any country in the world.
Officials have warned that the virus could return with a vengeance in the the coming months. The virus, already deemed at pandemic levels by global health experts, is in more than 100 countries and is continuing to spread.
Last week, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said clinical trials on a first candidate vaccine were expected to begin in August.
The tests would take "a couple of months" to determine whether the vaccine is safe and effective and what the appropriated dosage would be, Fauci said at a medical conference.

Date created : 2009-07-12